疫苗受怀疑者Robert F. Kennedy Jr.为健康和公众服务提名导致疫苗库存价格下跌。 Nomination of vaccine skeptic Robert F. Kennedy Jr. for Health and Human Services leads to vaccine stock prices dropping.

当选总统特朗普提名小罗伯特·肯尼迪(Robert F. Kennedy Jr.)担任卫生与公众服务部的领导, President-elect Trump has nominated Robert F. Kennedy Jr., a known vaccine skeptic, to lead the Department of Health and Human Services. 这一决定导致现代、辉瑞和Novavax等疫苗制造者的股票价格下降。 This decision has led to a decline in stock prices for vaccine makers such as Moderna, Pfizer, and Novavax. 卫生专家担心肯尼迪的反疫苗立场可能会阻碍疫苗接种,对公共卫生和公司利润产生负面影响。 Health experts worry that Kennedy’s anti-vaccine stance could discourage vaccinations and negatively impact public health and company profits.